News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ACE BioSciences A/S Divests Its Fast-Track Protein Identification Subsidiary, Alphalyse, In Management Buyout



10/19/2005 5:13:21 PM

ACE BioSciences A/S, the infectious diseases company, has divested Alphalyse A/S, its wholly owned, fast track protein identification subsidiary, in a management buy-out. Under the terms of the agreement, three members of staff will leave ACE BioSciences to join Alphalyse. They include Dr Thomas Kofoed, formerly Head of Protein Identification at ACE BioSciences and Chief Operating Officer of Alphalyse, who will be Chief Executive Officer of the newly independent entity. Financial details were not disclosed.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES